Business

LGC Capital Provides an Update on Little Green Pharma in Australia

LGC Capital Provides an Update on Little Green Pharma in Australia Canada NewsWire...

articleElixxer Ltd.June 19, 20185/company/elixxer-ltd-1/news/lgc-capital-provides-an-update-on-little-green-pharma-in-australia
LGC Capital Provides an Update on Little Green Pharma in Australia

About this update from Elixxer Ltd.

[{"type":"text","content":"\n\n\n\nLGC Capital Provides an Update on Little Green Pharma in Australia\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTREAL, June 19, 2018\n\n\n\nSymbol: TSX-V: LG\n\n\n\nMONTREAL, June 19, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) (\"LGC\") is pleased to announce it has been advised by Australian Medical Cannabis LP, Little Green Pharma, that on Thursday June 14, 2018, they received their final mandatory testing results from Australia's only TGA approved laboratory for medicinal cannabis testing and Little Green Pharma passed. This was the first time the laboratory had done the full suite of TGO 93 tests giving an indication that Little Green Pharma are on their way to having the first Australian produced medicinal cannabis for commercial sale. \n\n\n \n \n\n \nLittle Green Pharma's products are now being prepared at their manufacturing facility for stability testing, which will take about a month and a half after which product will be available for patients.\n\nBackground Information on TGO 93:TGO 93 applies to any medicinal cannabis product imported into, exported from, or supplied in Australia. The guidance is for manufacturers and sponsors, to assist in ensuring medicinal cannabis products conform with Therapeutic Goods Order No. 93, the Standard for Medicinal Cannabis. TGO 93 is a standard that specifies minimum quality requirements for medicinal cannabis products. The strict nature of the guidelines has resulted in many imported products being disallowed in Australia. For further information see Australian Government Department of Heath link at https://www.tga.gov.au/conforming-tgo-93-standard-medicinal-cannabis\n\nRenewed Licence:On 29 May 2018, Little Green Pharma received confirmation from the Office of Drug Control (ODC) that their Medicinal Cannabis Licence has been extended by two years, now expiring 28 May 2020. Little Green Pharma believe that this is the first time the ODC has extended a company's licence by more than 12 months.\n\nCurrent Crop:Crop #2 was planted shortly after the last harvest and Litt...

More updates from Elixxer Ltd.